COVID-19 in Indonesia: Where Are We?

Iwan Ariawan, Hafizah Jusril

Abstract


Since the 1st case officially confirmed on the last March 2020, Indonesia recorded more than 1000 new cases daily. The national trend shows no sign of decrease as 19 September 2020 the report sets a new mark of 4000 new cases in a day. The concept of controlling disease transmission relies on contacts suppression; and on the longer end, relies on vaccinations. As 27 September 2020, no vaccine is approved for use in the general population. Until then, countries should implement early, widespread, and strict disease mitigation strategies. While much remains to be learned on COVID-19, global evidence assert at least three strategies at the population level contributes to flatten the curve: mobility restriction, testing and isolation and rigorous contact-tracing.

Indonesia is not on entire absences of actions, but the epidemic calls for more. The central government called for social distancing two weeks after the first case confirmed and regulation on the large scale social distancing (Pembatasan Sosial Berskala Besar/ PSBB) that restrict non-essential population mobility is enacted by April 2020. Recent evidence outlines test, tracing and isolation are effective in suppressing COVID-19 transmission. Minimizing testing and tracing delay, less than four days with coverage of 80% close contacts could prevent and reduce onwards transmission.

That we need to more is indisputable. The vaccine is not a magic bullet; it is a long-term control measure and should be a complete series of careful and precise examinations. Indonesia will also likely require high coverage of vaccination to achieve herd immunity. At present, if there is no significant improvement in the coverage of preventive measures in the population and disease surveillance system, our hospital will be overwhelmed, and case fatality will be devastating.


Keywords


COVID-19; Indonesia; health system; test; tracing; treatment; mobility restriction

References


Badan Pusat Statistik. Statistik Indonesia 2019. Jakarta: Badan Pusat Statistik; 2019.

Mboi N, Murty Surbakti I, Trihandini I, et al. On the road to universal health care in Indonesia, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018; 392 (10147):581-91.

Satuan Tugas Penanganan COVID-19. Perkembangan kasus terkonfirmasi positif COVID-19 per-hari. 2020. https://covid19.go.id/peta-sebaran2020).

Muthiariny D. Jokowi admits Indonesia’s COVID-19 fatality rate higher than global average. Tempo. 2020 2 September 2020.

Bayham J, Fenichel EP. Impact of school closures for COVID-19 on the US health-care workforce and net mortality: a modelling study. Lancet Publ Health. 2020; 5(5): e271-e8.

Lau H, Khosrawipour V, Kocbach P, et al. The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China. J Travel Med. 2020; 27(3).

Ferguson N, Laydon D, Nedjati Gilani G, et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. 2020.

Kucharski AJ, Klepac P, Conlan AJK, et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. Lancet Infect Dis. 2020.

Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020.

Chu DK, Akl EA, Duda S, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020; 395(10242):1973-87.

Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science 2020.

World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 73. World Health Organization; 2020.

Ariawan I, Riono P, Farid MN, Jusril H, Wahyuningsih W. COVID-19 di Provinsi DKI Jakarta. Jakarta Indonesia; 2020.

Ariawan I, Riono P, Farid MN, Jusril H. An epidemiologic model for COVID-19 post-PSBB in Indonesia. Jakarta: FKM UI, 2020.

Ariawan I, Riono P, Farid MN, Jusril H. Pembatasan sosial di Indonesia: Apakah ada dampaknya terhadap epidemi COVID-19? Jakarta; 2020.

Phillips DL, Clancy KJ. Some effects of “social desirability” in survey studies. Am J Sociol. 1972; 77(5):921-40.

Cheng H-Y, Jian S-W, Liu D-P, et al. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med. 2020.

Kretzschmar ME, Rozhnova G, Bootsma MCJ, van Boven M, van de Wijgert JHHM, Bonten MJM. Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study. Lancet Publ Health. 2020;5(8):e452-e9.

MacIntyre CR. Case isolation, contact tracing, and physical distancing are pillars of COVID-19 pandemic control, not optional choices. Lancet Infect Dis. 2020; 20(10):1105-6.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Acta Medica Indonesiana